Meanwhile, we found that the mRNA and protein levels of TINAGL1 were slightly increased in Hep G2 cells treated with free-fatty acid (Figure S7B, C), hinting that TINAGL1 might serve as a factor in the pathogenesis of steatosis. The gene discussed is TINAGL1; the disease is steatosis.